Reporting Owner Activity for Dean J. Mitchell

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

Largest position

Theravance Biopharma, Inc.

Disclosed value

$2.49M

Recent activity

Available

Location: New York, NY
Ownership summary: Disclosed holdings value
$2,493,524
Estimated from parsed Forms 3/4/5 when holding values are disclosed.
Issuer positions
5
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest parsed position
Theravance Biopharma, Inc. (TBPH)
About $889.2K disclosed in parsed filings.
Latest ownership filing
25 Sep 2025
Most recent owner-level filing date in the parsed SEC record.
Theravance Biopharma, Inc. (TBPH)
Director - about $889.2K disclosed
PRECIGEN, INC. (PGEN)
Director - about $844.6K disclosed
Praxis Precision Medicines, Inc. (PRAX)
Director - about $759.7K disclosed
+2 more
Additional issuer positions are listed below.
Values come from parsed SEC Forms 3/4/5 and should be checked against the source filing before use.
Filing signature: /s/ Alex Nemiroff, as Attorney-in-Fact
Source filings: Open source filing history

Follow Filing Activity

Follow Dean J. Mitchell and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here